Methyl 1-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate, 97.0%, 1g

tert-Butyldimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)silane, 98+%, 5g

3-Vinylbenzoic acid, 95.0%, 100mg

Membrane de dialyse Spectra/Por® 1 à 4 Spectra/Por® 2 - MWCO 12 000 à 14 000, 25 mm, 1 Pièce(s)

Methyl 3-bromo-4-(difluoromethoxy)benzoate, 95.0%, 250mg

5-chloro-2-hydroxy-3-iodobenzaldehyde, 95.0%, 1g

2,4-DIMETHOXY-NAPHTHALENE-1-CARBALDEHYDE, 90.0%, 100mg

2-Pyrimidinamine, 4-(4-fluoro-1-naphthalenyl)-6-(1-methylethyl)-, hydrochloride (1:1), 98%, 10mg

4-(Azetidin-3-yl)pyridine dihydrochloride, 95.0%, 250mg

2-Hydroxy-4-phenyl-pyrimidine-5-carboxylic acid ethyl ester, 95.0%, 10g

Ethyl 4-methoxy-3-oxobutanoate, 95.0%, 10g

1-(4-bromophenyl)-4,5-dihydro-1H-1,2,4-triazol-5-one, 97%, 100mg

(S)-(+)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)dimethylamine>98.0%(HPLC)(T)5g